Kyle Chan

Senior Leader @ Get on Track Biotech (GOTBio)

Country

United States

City

San Diego

Industry

Biotechnology

Skill

Experience

Senior Leader

Get on Track Biotech (GOTBio)

2025-1 - Present · 1 yr 9 mos

San Diego, California, United States

Chairperson of the Board

Abcon Therapeutics

2022 - Present · 4 yrs

Cleveland, Ohio, United States

Abcon Therapeutics is dedicated to the development of first-in-class therapeutics for T-cell mediated diseases and related cancers.

Chief Scientific Officer

NovoMedix

2022 - Present · 4 yrs

Scientific Advisor

NovoMedix

2007 - 2022 · 15 yrs

Co-founder, Chief Technology Officer

Biotheryx, Inc.

2007-7 - 2022-2 · 14 yrs 8 mos

Member Board of Directors

TheraVasc Inc

2010 - 2017 · 7 yrs

Theravasc developed orally available treatment for peripheral artery disease and non-opioid treatment for neuropathic pain.

Scientific Advisory Panel

EMD Biosciences

2009 - 2010 · 1 yr

Advised on potential new products for brands Calbiochem, Novabiochem, and Novagen. They were collectively known as EMD Chemicals, an affiliate of Merck KGaA and based in San Diego.

Strategic Advisory Board

Medistem

2007 - 2009 · 2 yrs

Scottsdale, Arizona, United States

Medistem commercialized advanced medical therapies based on non-controversial adult stem cells targeting neurological disorders and cancer.

Sr. Director Discovery Research

Signal Research Division of Celgene

1998 - 2007 · 9 yrs

Directed a multidisciplinary department that integrates bioinformatics and experimental therapeutics including all Functional Genomics, Proteomics, Drug Discovery Technologies and Informatics. Worked closely with marketing and clinical research to formulate strategy for potential new markets for new products and new uses of current products. Performed due diligence of technologies and business strategies for external colleagues and investors.